Pfizer Inc.
PFIZER INC., $40.39, New York symbol PFE, is a buy.
The company is one of the world’s largest makers of prescription drugs. Its top-selling brands include Enbrel (arthritis), Ibrance (breast cancer) and Prevnar (pneumonia).
Pfizer has increased its dividend rate each year since 2011....
The company is one of the world’s largest makers of prescription drugs. Its top-selling brands include Enbrel (arthritis), Ibrance (breast cancer) and Prevnar (pneumonia).
Pfizer has increased its dividend rate each year since 2011....
PFIZER INC., $40.10, New York symbol PFE, is a buy.
The company is one of the world’s largest makers of prescription drugs. Its top-selling brands include Enbrel (arthritis), Ibrance (breast cancer) and Prevnar (pneumonia).
Pfizer has agreed to acquire Seagen Inc....
The company is one of the world’s largest makers of prescription drugs. Its top-selling brands include Enbrel (arthritis), Ibrance (breast cancer) and Prevnar (pneumonia).
Pfizer has agreed to acquire Seagen Inc....
AGILENT TECHNOLOGIES INC., $143.93, New York symbol A, is still a buy for aggressive investors.
The company makes specialized testing equipment for medical research laboratories and industrial clients. Its equipment includes mass spectrometers, used to analyze substances.
Demand for Agilent’s equipment from pharmaceutical firms, chemical makers and food producers remains strong as the economy recovers from the COVID-19 pandemic....
The company makes specialized testing equipment for medical research laboratories and industrial clients. Its equipment includes mass spectrometers, used to analyze substances.
Demand for Agilent’s equipment from pharmaceutical firms, chemical makers and food producers remains strong as the economy recovers from the COVID-19 pandemic....
ALPHABET INC., Nasdaq symbols GOOG $105.22 [class C: non-voting] and GOOGL $104.78 [class A: one vote per share], is your #1 Aggressive buy for 2023.
The company is the parent of Google, the world’s leading Internet search engine—it handles over 80% of global search requests....
The company is the parent of Google, the world’s leading Internet search engine—it handles over 80% of global search requests....
DUN & BRADSTREET HOLDINGS INC. $14 remains a buy. The company (New York symbol DNB; Aggressive Growth Portfolio, Finance sector; Shares outstanding: 433.8 million; Market cap: $6.1 billion; Price-to-sales ratio: 2.7; Dividend yield: 1.4%; TSINetwork Rating: Extra Risk; www.dnb.com) continues to benefit from its January 2021 acquisition of Bisnode Business Information Group AB for $805.8 million in cash and shares....
BANK OF MONTREAL, $122.61, Toronto symbol BMO, remains a buy.
With the February 2023 payment, Bank of Montreal will raise your quarterly dividend by 2.9%, to $1.43 a share from $1.39. The new annual rate of $5.72 yields a high 4.7%.
In December 2021, the bank agreed to acquire California-based Bank of the West from France’s BNP Paribas for $16.3 billion U.S.
Bank of the West provides a variety of retail and commercial banking services to over 1.8 million customers through 514 branches in 24 states, mainly in the Western and Midwestern regions of the U.S....
With the February 2023 payment, Bank of Montreal will raise your quarterly dividend by 2.9%, to $1.43 a share from $1.39. The new annual rate of $5.72 yields a high 4.7%.
In December 2021, the bank agreed to acquire California-based Bank of the West from France’s BNP Paribas for $16.3 billion U.S.
Bank of the West provides a variety of retail and commercial banking services to over 1.8 million customers through 514 branches in 24 states, mainly in the Western and Midwestern regions of the U.S....
PFIZER INC., $51.43, New York symbol PFE, is your #1 Income Buy for 2022.
The company is one of the world’s largest makers of prescription drugs. Its top-selling brands include Eliquis (stroke), Ibrance (breast cancer) and Prevnar (pneumonia).
Pfizer has increased its dividend rate each year since 2011....
The company is one of the world’s largest makers of prescription drugs. Its top-selling brands include Eliquis (stroke), Ibrance (breast cancer) and Prevnar (pneumonia).
Pfizer has increased its dividend rate each year since 2011....
Traditionally, the price of most stocks, and the ETFs that hold them, drop during bear markets like the one we saw in 2022. However, certain segments generally perform better than the overall market during downturns—and bounce back faster, including during the 2000-2002 and 2008-2009 bear markets.
Below, we highlight three ETFs focused on resilient market segments: value stocks, military defence and healthcare....
Below, we highlight three ETFs focused on resilient market segments: value stocks, military defence and healthcare....
Merck—like other big pharmaceutical makers Pfizer and Johnson & Johnson—recently spun off some of its legacy businesses. Merck’s split came in June 2021 with the creation of Organon & Co. Investors received one share in the new firm for every 10 Merck shares they held.
Since the Organon spinoff, its former parent has gained 32%, which is far better than the 6% decline for the S&P 500 Index over that same period....
Since the Organon spinoff, its former parent has gained 32%, which is far better than the 6% decline for the S&P 500 Index over that same period....
BCE INC., $62.53, Toronto symbol BCE, is a buy.
The company is Canada’s largest traditional telephone service provider: it has 2.16 million residential customers in Ontario, Quebec, Manitoba and the Atlantic provinces. BCE also has 4.07 million high-speed Internet users and 2.74 million TV subscribers (satellite and fibre-optic)....
The company is Canada’s largest traditional telephone service provider: it has 2.16 million residential customers in Ontario, Quebec, Manitoba and the Atlantic provinces. BCE also has 4.07 million high-speed Internet users and 2.74 million TV subscribers (satellite and fibre-optic)....